Invention Grant
US07750050B2 Chaperone-based therapy for Niemann-Pick disease 失效
基于伴侣疗法的尼曼 - 皮克病

Chaperone-based therapy for Niemann-Pick disease
Abstract:
The present invention provides a method for treating individuals affected with the acid sphingomyelinase-deficient forms of Niemann-Pick disease (i.e., Type A or Type B Niemann-Pick) by administering small molecules as specific molecular “chaperones” for the deficient acid sphingomyelinase (ASM) enzyme associated with the disease. The molecules are ceramide, sphingomyelin, or phosphonucleotide analogues.
Public/Granted literature
Information query
Patent Agency Ranking
0/0